Determinants for Clinical Diagnosis of Hypertrophic Cardiomyopathy

American Journal of Cardiology

Volumn 98, Issue 11, 2006, Pages 1507-1511

  Adabag, A Selcuk ^b   Kuskowski, Michael A ^b   Maron, Barry J ^a  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HIGH RISK PATIENT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; STROKE;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; SPORTS;

EID: 33751245882     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.07.029     Document Type: Article

References (24)

1. Wigle E.D., Rakowski H., Kimball B.P., and Williams W.G. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 92 (1995) 1680-1692
2. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
3. Maron M.S., Olivotto I., Betocchi S., Casey S.A., Lesser J.R., Losi M.A., Cecchi F., and Maron B.J. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348 (2003) 295-303
4. Spirito P., Seidman C.E., McKenna W.J., and Maron B.J. The management of hypertrophic cardiomyopathy. N Engl J Med 336 (1997) 775-785
5. Nicod P., Polikar R., and Peterson K.L. Hypertrophic cardiomyopathy and sudden death. N Engl J Med 318 (1988) 1255-1257
6. Maron B.J., Shen W.-K., Link M.S., Epstein A.E., Almquist A.K., Daubert J.P., Brady G.H., Favale S., Rea R.F., Boriani G., et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 365-373
7. Maron B.J. Hypertrophic cardiomyopathy: an important global disease. Am J Med 116 (2004) 63-65
8. Maron B.J., Peterson E.E., Maron M.S., and Peterson J.E. Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study. Am J Cardiol 73 (1994) 577-580
9. Maron B.J., Spirito P., Roman M.J., Paranicas M., Okin P.M., Best L.G., Lee E.T., and Devereux R.B. Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study). Am J Cardiol 93 (2004) 1510-1514
10. Maron B.J., Gardin J.M., Flack J.M., Gidding S.S., Kurosaki T.T., and Bild D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary Artery Risk Development in (Young) Adults. Circulation 92 (1995) 785-789
11. Zou Y., Song L., Wang Z., Ma A., Liu T., Gu H., Lu S., Wu P., Zhang Y., Shen L., et al. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. Am J Med 116 (2004) 14-18
12. Malcic I., Jelusic M., Kniewald H., Barisic N., Jelasic D., and Bozikov J. Epidemiology of cardiomyopathies in children and adolescents: retrospective study over the last 10 years. Cardiol Young 12 (2002) 253-259
13. Klues H.G., Schiffers A., and Maron B.J. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26 (1995) 1699-1708
14. Wigle E.D., Sasson Z., Henderson M.A., Ruddy T.D., Fulop J., Rakowski H., and Williams W.G. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis 28 (1985) 1-83
15. Spirito P., Bellone P., Harris K.M., Bernabo P., Bruzzi P., and Maron B.J. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 1778-1785
16. Olivotto I., Maron M.S., Adabag A.S., Casey S.A., Vargiu D., Link M.S., Udelson J.E., Cecchi F., and Maron B.J. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol 46 (2005) 480-487
17. Elliott P.M., Poloniecki J., Dickie S., Sharma S., Monserrat L., Varnava A., Mahon N.G., and McKenna W.J. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36 (2000) 2212-2218
18. Maron B.J., Estes III N.A., Maron M.S., Almquist A.K., Link M.S., and Udelson J.E. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. Circulation 107 (2003) 2872-2875
19. Maron B.J., Shirani J., Poliac L.C., Mathenge R., Roberts W.C., and Mueller F.O. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 276 (1996) 199-204
20. Corrado D., Basso C., Schiavon M., and Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 339 (1998) 364-369
21. Pfister G.S., Puffer J.C., and Maron B.J. Preparticipation cardiovascular screening for US collegiate student-athletes. JAMA 283 (2000) 2597-2599
22. Glover D.W., and Maron B.J. Profile of preparticipation cardiovascular screening for high school athletes. JAMA 279 (1998) 1817-1819
23. Maron B.J. Sudden death in young athletes. N Engl J Med 349 (2003) 1064-1075
24. Maron B.J., McKenna W.J., Danielson G.K., Kappenberger L.J., Kuhn H.J., Seidman C.E., Shah P.M., Spencer W.H., Spirito P., ten Cate F.J., and Wigle E.D. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy. J Am Coll Cardiol 142 (2003) 1687-1713